Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 27 July 2021, 08:00 HKT/SGT

Source: Cryoviva Singapore
Singapore cord blood bank Cryoviva establishes footprint in the UAE
Builds on a strong foundations in Singapore to help families in Dubai and the UAE benefit from the growing interest and acceptance of cord component storage for possible stem cell treatments later on. Many families in the UAE have opted to store their baby's cord blood in Cryoviva's facility in Singapore.

Singapore, July 27, 2021 - (ACN Newswire) - Family cord blood bank Cryoviva Singapore is pleased to announce that it has made a successful foray into the UAE market in line with its strategic growth plans. After 7 years of serving young families in Singapore, the expansion into Dubai and the other Emirates in the UAE is an important milestone for Cryoviva.

Rajesh Nair, CEO of Cryoviva Singapore

"This is an important step in our journey, fulfilling our mission to give every family the chance to benefit from the medical potential of cord stem cells should they need it. That we have been able to attract young families in the UAE to trust us with their baby's precious cord blood is not only a testament to our credentials as a company, but also to Singapore's reputation for world-class facilities and strict adherence to high-quality standards. We invite healthcare providers offering maternity services to collaborate with us to provide even greater service to their valued patients," said Rajesh Nair, CEO of Cryoviva Singapore.

"While we continue with our growth efforts in several other countries - both in the ASEAN region as well as in the Middle East, I would also like to reiterate our commitment to serving families in Singapore. We believe that there is still considerable potential for family cord blood banking services to grow in a developed and discerning market like Singapore. We also look forward to contributing to further our city's position as a great destination to avail of world-class healthcare services."

About Cryoviva Singapore

Established in 2014, Cryoviva ( is a well-regarded family cord blood bank in Singapore. The company is part of an international group backed by multinational investors. The Cryoviva group has successfully stored over 160,000 cord blood units. Cryoviva's cord blood storage facility in Singapore is MoH-licensed, AABB accredited and IS ISO 9001:2015 QMS Certified, testaments to the stringent processes and quality standards that it adheres to. With its central location and proximity to most major maternity hospitals in Singapore, cord blood samples reach our facilities quickly and efficiently to ensure top quality maintenance upon storage.

Media Contact:
Krish Sharma, General Manager
Cryoviva Singapore,
Tel: +65-9651 7080

Topic: Press release summary
Source: Cryoviva Singapore

Sectors: BioTech, Healthcare & Pharm, Clinical Trials
From the Asia Corporate News Network

Copyright © 2022 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

Cryoviva Singapore
Nov 2, 2021 08:30 HKT/SGT
Cryoviva Singapore Gets AABB Accreditation for Somatic Cells' Processing, Storage, and Distribution
Sept 7, 2021 12:20 HKT/SGT
Cryoviva Singapore Expands Cord Blood Banking Services to Bahrain
More news >>
 News Alerts
Copyright © 2022 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: